Faith Barnett, MD, PhD, FAANS - Dr. Barnett is the Founder and CEO of Resolute Science, a preclinical-stage biotechnology company developing a novel class of pan-cancer therapeutics targeting aggressive and hard-to-treat solid tumors. Dr. Barnett is a neurosurgeon and director of the neuro-oncology program at Scripps Cancer Center and director of quality assurance for surgical programs. She obtained her MD and PhD from Harvard Medical School through the Harvard-MIT Health Sciences and Technology Program, completed her neurosurgical training at Brigham & Women’s Hospital, and her pediatric neurosurgery fellowship at Boston Children’s Hospital. Prior to Resolute, she had a research focus on therapeutic approaches to brain tumors, tumor angiogenesis and macrophage biology. She has received numerous honors, including Phi Beta Kappa, Max Tennis Humanitarian Award, Skaggs Clinical Scholar, and Gittes-Thornburg award.